ArticleFrontiers in immunology2024

Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model.

Daniel R Bergman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.